Terry Vance Net Worth & Insider Trades

Terry Vance - Director, Enanta Pharmaceuticals Inc

As of March 7, 2022

What is Terry Vance's Net Worth?

The current estimated net worth of Enanta Pharmaceuticals Inc's Director, Terry Vance, is estimated to be about $802.99K . Terry Vance owns about 15,295 units of Enanta Pharmaceuticals Inc common stock. In the last 9 years at Enanta Pharmaceuticals Inc, Terry Vance has sold an estimated value of $0 worth.

What is Terry Vance's Past Insider Trading?

Terry Vance's largest purchase order was 13,295 units , worth over $186.13K on March 28, 2013. In total, Terry Vance has made about 12 transactions over 9 years of their time at Enanta Pharmaceuticals Inc. Terry Vance usually trades in March and February, with the busiest year in 2013 and 2016. The most recent transaction was a purchase order of 2,000 units , worth over $54.08K on February 17, 2016.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Terry Vance's' Mailing Address?

  • Mailing address is C/o Enanta Pharmaceuticals, Inc. 500 Arsenal Street Watertown MA 02472 MA

What are Enanta Pharmaceuticals Inc's Past Insider Trades?

Enanta Pharmaceuticals Inc's most recent insider trade came on December 16, 2022 by Jay Luly who sold 30,000 units worth $1.34M . In the last 9 years, insiders at Enanta Pharmaceuticals Inc have sold an estimated value of $99.61M and bought an estimated value of $18.94M worth of shares. Insider trading is most common in February, with the busiest year in 2014. The most active traders at the company are Paul Mellett, Treasurer and CFO,  Jay Luly, President and CEO,  and Nathaniel S. Gardiner As Attorney-In-Fact, Sr. VP & CSO .

ENANTA PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1